Share on Pinterest Researchers have compared the effectiveness of weight loss medications such as tirzepatide and semaglutide. Jaap Arriens/NurPhoto via Getty Images Tirzepatide and semaglutide are ...

Researchers from Truveta, a health data analytics company, analyzed electronic health records for more than 18,000 adults, all of whom had overweight or obesity, who were using these medications in ...

Tirzepatide, the active ingredient in the diabetes drug Mounjaro, helped people lose more than 60 pounds (lb), or at least one-quarter of their body weight, when used along with intensive lifestyle ...

A winner has emerged in the ongoing battle of the bulge: Mounjaro. Overweight or obese adults are three times more likely to shed 15% of their body weight on Mounjaro than Ozempic, according to a ...

Please provide your email address to receive an email when new articles are posted on . A dose of 15 mg tirzepatide produced a mean weight loss of 15% in patients after a year of treatment. Some of ...

BELLEVUE, Wash., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new comparative effectiveness research exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide ...

Overweight and obese patients taking weight loss and diabetes drug tirzepatide—the generic name for Mounjaro and Zepbound—saw significant reductions in their blood pressure, according to a new study ...

Results from a recent study suggest that tirzepatide may be more effective in helping people who have obesity or overweight lose weight than semaglutide. People interested in using medications for ...